Wells Fargo Upgrades Relay Therapeutics (RLAY) to Overweight

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 6/13/2026

1. ORCL
2. SPY
3. SPCX
4. USO
5. CHWY

6. NAVN
7. HUMA
8. NVDA
9. CRWV
10. CME

Price: $9.89 +2.59%

Rating Summary:
14 Buy, 0 Hold, 0 Sell

Rating Trend:

Up

Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0

Wells Fargo analyst Eva Fortea Verdejo upgraded Relay Therapeutics (NASDAQ: RLAY) from Equal Weight to Overweight with a price target of $13.00.

For an analyst ratings summary and ratings history on Relay Therapeutics click here. For more ratings news on Relay Therapeutics click here.

Shares of Relay Therapeutics closed at $7.79 yesterday.

Upgrades

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!